Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

Presentation TCT 2023

Industry Perspective

Presenter: Lars Sondergaard

October 23, 2023

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

Presentation TCT 2019

TAVR in Bicuspid Aortic Valves

Presenter: Lars Sondergaard

September 25, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

Presentation TCT 2018

PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Presenter: James B. Hermiller Jr, Lars Sondergaard

September 25, 2018

Presentation TCT 2018

PFO Closure With the CardioForm: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

Presenter: William A. Gray, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Case #3: A Complex PFO Closure With Technique Challenges

Presenter: William A. Gray, Horst Sievert, Steven R. Bailey, Nirat Beohar, Brian Clapp, Eric Eeckhout, Franz X. Kleber, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Evolving PFO Closure Practice and Challenges in Europe

Presenter: Teiji Akagi, John D. Carroll, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Device Selection and CT Sizing for TAVR Treatment of BAV

Presenter: Joseph E. Bavaria, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Percutaneous PFO Closure: Finally Arrived?

Presenter: Jeroen J. Bax, Stephan Windecker, Lars Sondergaard

September 21, 2018

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

The PFO Clinic: Neurologists and Cardiologists as a Team

Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

Advertisement

Industry Perspective

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

TAVR in Bicuspid Aortic Valves

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

PFO Closure With the CardioForm: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

Case #3: A Complex PFO Closure With Technique Challenges

Evolving PFO Closure Practice and Challenges in Europe

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Device Selection and CT Sizing for TAVR Treatment of BAV

Percutaneous PFO Closure: Finally Arrived?

RESOLVE/SAVORY: Topline Findings and Practice Implications

The PFO Clinic: Neurologists and Cardiologists as a Team

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content